CDC25B Is a Prognostic Biomarker Associated With Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma
Cell division cycle 25B (CDC25B), a member of the CDC25 phosphatase family, plays a key role in cell cycle regulation. Studies have suggested its carcinogenic potential in various cancers, but the role of CDC25B in the development of hepatocellular carcinoma (HCC) remains poorly understood. The aim...
Saved in:
Main Authors: | Zixiang Huang, Liangzhi Xu, Zhengqiang Wu, Xiaofeng Xiong, Linfei Luo, Zhili Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2024/8922878 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Sheng Cheng, et al.
Published: (2023-01-01) -
Biomarkers for Hepatocellular Carcinoma
by: Tara Behne, et al.
Published: (2012-01-01) -
NOL-7 serves as a potential prognostic-related biomarker for hepatocellular carcinoma
by: Qiucheng Lei, et al.
Published: (2025-01-01) -
CDC25A Mediates Survival by Activating AKT Kinase
by: C. Leisser, et al.
Published: (2001-01-01) -
Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence
by: Jing-Xuan Xu, et al.
Published: (2025-12-01)